Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 11 | 2024 | 292 | 1.680 |
Why?
|
| Substance-Related Disorders | 16 | 2022 | 825 | 1.300 |
Why?
|
| Yoga | 3 | 2022 | 33 | 1.080 |
Why?
|
| Alcohol Drinking | 8 | 2023 | 585 | 0.970 |
Why?
|
| Meditation | 2 | 2022 | 25 | 0.930 |
Why?
|
| Mental Disorders | 5 | 2021 | 377 | 0.810 |
Why?
|
| Agrochemicals | 1 | 2021 | 6 | 0.730 |
Why?
|
| Hepatitis C | 1 | 2022 | 138 | 0.710 |
Why?
|
| Emigration and Immigration | 1 | 2021 | 85 | 0.700 |
Why?
|
| Central Nervous System Stimulants | 1 | 2022 | 181 | 0.680 |
Why?
|
| Mental Health | 2 | 2022 | 363 | 0.680 |
Why?
|
| Adolescent | 24 | 2023 | 5950 | 0.670 |
Why?
|
| Minority Groups | 6 | 2024 | 663 | 0.660 |
Why?
|
| Peer Group | 3 | 2023 | 173 | 0.630 |
Why?
|
| Humans | 47 | 2024 | 42163 | 0.570 |
Why?
|
| Bariatric Surgery | 4 | 2018 | 20 | 0.540 |
Why?
|
| Social Identification | 1 | 2015 | 63 | 0.450 |
Why?
|
| Prejudice | 1 | 2015 | 116 | 0.440 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 128 | 0.440 |
Why?
|
| Aggression | 1 | 2014 | 101 | 0.410 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2022 | 46 | 0.400 |
Why?
|
| Motivation | 5 | 2024 | 492 | 0.380 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2018 | 172 | 0.360 |
Why?
|
| Female | 21 | 2023 | 24018 | 0.360 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 358 | 0.350 |
Why?
|
| Male | 20 | 2023 | 22779 | 0.350 |
Why?
|
| Adult | 15 | 2023 | 13458 | 0.330 |
Why?
|
| United States | 7 | 2023 | 5072 | 0.320 |
Why?
|
| Florida | 7 | 2022 | 461 | 0.320 |
Why?
|
| Health Promotion | 3 | 2018 | 691 | 0.320 |
Why?
|
| Adolescent Behavior | 4 | 2004 | 270 | 0.310 |
Why?
|
| Young Adult | 9 | 2024 | 4936 | 0.290 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 29 | 0.290 |
Why?
|
| HIV Infections | 3 | 2020 | 2535 | 0.280 |
Why?
|
| Adolescent Development | 1 | 2008 | 39 | 0.280 |
Why?
|
| Social Work, Psychiatric | 2 | 2003 | 3 | 0.250 |
Why?
|
| Postoperative Complications | 2 | 2018 | 253 | 0.230 |
Why?
|
| Students | 3 | 2022 | 617 | 0.230 |
Why?
|
| Risk-Taking | 2 | 2004 | 456 | 0.210 |
Why?
|
| Crime Victims | 1 | 2004 | 77 | 0.210 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2008 | 116 | 0.200 |
Why?
|
| Violence | 1 | 2004 | 133 | 0.200 |
Why?
|
| Drug and Narcotic Control | 1 | 2003 | 11 | 0.200 |
Why?
|
| Models, Organizational | 1 | 2003 | 35 | 0.200 |
Why?
|
| Narcotics | 1 | 2022 | 30 | 0.200 |
Why?
|
| Vaccination | 2 | 2022 | 332 | 0.190 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 216 | 0.190 |
Why?
|
| Culture | 2 | 2019 | 172 | 0.190 |
Why?
|
| Social Justice | 1 | 2003 | 64 | 0.190 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 234 | 0.190 |
Why?
|
| Occupations | 1 | 2021 | 27 | 0.180 |
Why?
|
| Prednisolone | 1 | 2021 | 16 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 11 | 0.180 |
Why?
|
| Concept Formation | 1 | 2021 | 25 | 0.170 |
Why?
|
| Juvenile Delinquency | 2 | 2016 | 44 | 0.170 |
Why?
|
| Ethanol | 1 | 2023 | 221 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 188 | 0.170 |
Why?
|
| Longevity | 1 | 2022 | 171 | 0.170 |
Why?
|
| PAX7 Transcription Factor | 1 | 2020 | 3 | 0.170 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2020 | 9 | 0.170 |
Why?
|
| Education, Pharmacy | 1 | 2021 | 56 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2021 | 633 | 0.160 |
Why?
|
| Indians, North American | 1 | 2022 | 179 | 0.160 |
Why?
|
| Students, Pharmacy | 1 | 2021 | 57 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2022 | 733 | 0.160 |
Why?
|
| Directive Counseling | 2 | 2014 | 16 | 0.160 |
Why?
|
| Condoms | 1 | 2020 | 148 | 0.150 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 410 | 0.150 |
Why?
|
| Focus Groups | 2 | 2018 | 398 | 0.150 |
Why?
|
| Refugees | 1 | 2019 | 21 | 0.150 |
Why?
|
| Child | 4 | 2022 | 3381 | 0.150 |
Why?
|
| Student Health Services | 1 | 2018 | 12 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 308 | 0.150 |
Why?
|
| Counseling | 1 | 1999 | 134 | 0.140 |
Why?
|
| Schools | 2 | 2014 | 283 | 0.140 |
Why?
|
| Anxiety | 2 | 2022 | 847 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 532 | 0.140 |
Why?
|
| Program Evaluation | 1 | 1999 | 358 | 0.140 |
Why?
|
| Spinal Dysraphism | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cerebral Palsy | 1 | 2017 | 14 | 0.140 |
Why?
|
| Patient Selection | 1 | 2019 | 192 | 0.140 |
Why?
|
| Cultural Competency | 1 | 2018 | 137 | 0.130 |
Why?
|
| Perception | 1 | 2018 | 209 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2022 | 70 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 66 | 0.130 |
Why?
|
| Hypertension | 1 | 2023 | 823 | 0.130 |
Why?
|
| Criminals | 1 | 2016 | 18 | 0.130 |
Why?
|
| Prevalence | 6 | 2019 | 1597 | 0.130 |
Why?
|
| Alcohols | 1 | 2016 | 14 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2017 | 180 | 0.120 |
Why?
|
| Patient Preference | 1 | 2016 | 55 | 0.120 |
Why?
|
| Sexual Behavior | 3 | 2020 | 634 | 0.120 |
Why?
|
| Social Environment | 1 | 2016 | 218 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2016 | 185 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 309 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 471 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2008 | 1586 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2014 | 141 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 1999 | 641 | 0.100 |
Why?
|
| Risk Factors | 7 | 2019 | 3942 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 467 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 547 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 1051 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2008 | 81 | 0.070 |
Why?
|
| Models, Psychological | 2 | 2010 | 141 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1139 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2004 | 56 | 0.050 |
Why?
|
| Cyclins | 1 | 2004 | 37 | 0.050 |
Why?
|
| Sirolimus | 1 | 2004 | 70 | 0.050 |
Why?
|
| Parents | 3 | 2016 | 359 | 0.050 |
Why?
|
| Human Rights | 1 | 2003 | 11 | 0.050 |
Why?
|
| Harm Reduction | 1 | 2003 | 27 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 8 | 0.050 |
Why?
|
| Myofibrils | 1 | 2022 | 12 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1020 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2485 | 0.050 |
Why?
|
| Age of Onset | 1 | 2002 | 115 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 255 | 0.050 |
Why?
|
| Muscle Development | 1 | 2022 | 51 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 236 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 335 | 0.050 |
Why?
|
| Health Education | 1 | 2005 | 358 | 0.050 |
Why?
|
| Dystrophin | 1 | 2021 | 20 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 378 | 0.040 |
Why?
|
| Health Policy | 1 | 2003 | 184 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2004 | 359 | 0.040 |
Why?
|
| Kidney | 1 | 2023 | 363 | 0.040 |
Why?
|
| Pharmacists | 1 | 2021 | 56 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 100 | 0.040 |
Why?
|
| Myogenin | 1 | 2020 | 6 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2021 | 127 | 0.040 |
Why?
|
| Cues | 1 | 2020 | 75 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 238 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2020 | 148 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2020 | 102 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 104 | 0.040 |
Why?
|
| Incidence | 1 | 2002 | 1054 | 0.040 |
Why?
|
| Self Efficacy | 2 | 2016 | 211 | 0.040 |
Why?
|
| Demography | 1 | 1999 | 195 | 0.040 |
Why?
|
| Forecasting | 1 | 1999 | 136 | 0.040 |
Why?
|
| Sex Factors | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Iran | 1 | 2019 | 199 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 311 | 0.040 |
Why?
|
| Communication | 1 | 2020 | 207 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 539 | 0.040 |
Why?
|
| Calcium | 1 | 2021 | 487 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 774 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 33 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2019 | 134 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 1416 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 708 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2018 | 428 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2019 | 526 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 1169 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1617 | 0.030 |
Why?
|
| Poverty | 1 | 2019 | 395 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 19 | 0.030 |
Why?
|
| Program Development | 1 | 2016 | 237 | 0.030 |
Why?
|
| Alcohol-Related Disorders | 1 | 2015 | 63 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 165 | 0.030 |
Why?
|
| Social Support | 1 | 2016 | 438 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1574 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2010 | 35 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 125 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 959 | 0.020 |
Why?
|
| Models, Educational | 1 | 2005 | 46 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cyclin D3 | 1 | 2004 | 3 | 0.010 |
Why?
|
| Ionomycin | 1 | 2004 | 11 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2004 | 8 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 25 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 42 | 0.010 |
Why?
|
| G1 Phase | 1 | 2004 | 33 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 84 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 95 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 244 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 206 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 147 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 2002 | 17 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 638 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2002 | 179 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1848 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 3077 | 0.010 |
Why?
|